Metastatic breast cancer treated with lapatinib with a prolonged benefit: A case report and a review of therapeutic options available

Giulia Valeria Bianchi, Matteo Duca, Lorenzo Sica, Gabriella Mariani

Research output: Contribution to journalArticle

Abstract

A 53-year-old woman was treated, after trastuzumab progression of HER2-positive metastatic disease, with capecitabine plus lapatinib and subsequently with lapatinib alone. To date, she has had persistent remission of disease since 2009. Copyright - Il Pensiero Scientifico Editore.

Original languageEnglish
JournalTumori
Volume99
Issue number6
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Lapatinib
  • Metastatic breast cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Metastatic breast cancer treated with lapatinib with a prolonged benefit: A case report and a review of therapeutic options available'. Together they form a unique fingerprint.

  • Cite this